These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 24751181)
1. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Steinau M; Saraiya M; Goodman MT; Peters ES; Watson M; Cleveland JL; Lynch CF; Wilkinson EJ; Hernandez BY; Copeland G; Saber MS; Hopenhayn C; Huang Y; Cozen W; Lyu C; Unger ER; Emerg Infect Dis; 2014 May; 20(5):822-8. PubMed ID: 24751181 [TBL] [Abstract][Full Text] [Related]
2. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT; J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419 [TBL] [Abstract][Full Text] [Related]
3. The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry. Cleveland JL; Junger ML; Saraiya M; Markowitz LE; Dunne EF; Epstein JB J Am Dent Assoc; 2011 Aug; 142(8):915-24. PubMed ID: 21804058 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States. Mix JM; Saraiya M; Thompson TD; Querec TD; Greek A; Tucker TC; Peters ES; Lynch CF; Hernandez BY; Copeland G; Goodman MT; Unger ER Cancer; 2021 Oct; 127(19):3614-3621. PubMed ID: 34289090 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy? Osazuwa-Peters N Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883 [TBL] [Abstract][Full Text] [Related]
6. Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study. Landy R; Haber G; Graubard BI; Campos NG; Sy S; Kim JJ; Burger EA; Cheung LC; Katki HA; Gillison ML; Chaturvedi AK J Natl Cancer Inst; 2023 Apr; 115(4):429-436. PubMed ID: 36655795 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-associated cancers - United States, 2004-2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial. Lehtinen M; Apter D; Eriksson T; Harjula K; Hokkanen M; Lehtinen T; Natunen K; Damaso S; Soila M; Bi D; Struyf F Int J Cancer; 2020 Jul; 147(1):170-174. PubMed ID: 31736068 [TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014. Oliver SE; Gorbach PM; Gratzer B; Steinau M; Collins T; Parrish A; Kerndt PR; Crosby RA; Unger ER; Markowitz LE; Meites E Sex Transm Dis; 2018 Oct; 45(10):660-665. PubMed ID: 30204745 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. Gillison ML J Adolesc Health; 2008 Oct; 43(4 Suppl):S52-60. PubMed ID: 18809146 [TBL] [Abstract][Full Text] [Related]
11. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017. Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540 [TBL] [Abstract][Full Text] [Related]
13. HPV Vaccine Slashes Rates of Oral Infection. Cancer Discov; 2017 Jul; 7(7):OF6. PubMed ID: 28526738 [TBL] [Abstract][Full Text] [Related]
14. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France. Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423 [TBL] [Abstract][Full Text] [Related]
15. Extended coverage of HPV vaccination in middle-aged adults to prevent oropharyngeal cancers. Arya SC; Agarwal N Hum Vaccin Immunother; 2012 Jul; 8(7):959. PubMed ID: 22777098 [No Abstract] [Full Text] [Related]
16. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J BMJ; 2015 May; 350():h2016. PubMed ID: 25985328 [TBL] [Abstract][Full Text] [Related]
17. A Multi-state Evaluation of Oral Health Students' Knowledge of Human Papillomavirus-Related Oropharyngeal Cancer and HPV Vaccination. Rutkoski H; Tay DL; Dixon BL; Pinzon LM; Mooney R; Winkler JR; Kepka D J Cancer Educ; 2020 Oct; 35(5):1017-1025. PubMed ID: 31222578 [TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of HPV-related cancers in the US veteran population. Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867 [TBL] [Abstract][Full Text] [Related]
20. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Guo T; Eisele DW; Fakhry C Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]